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Retraction
The corresponding author submitted this article [1] to
Journal of Experimental and Clinical Cancer Research
although this article had been accepted and previously
published by Cancer Biotherapy & Radiopharmaceuticals [2].
The article was also received and subsequently accepted
and published by Nucleosides, Nucleotides and Nucleic Acids
[3]. Since it has been brought to the attention of all
authors that duplicate submission and publication have
taken place the decision has been made to retract the arti-
cle published in Journal of Experimental and Clinical Cancer
Research. The authors are deeply sorry for any inconven-
ience this may have caused to the editorial staff and read-
ers.
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